Evidence map›Paper›PMID 33198289›Full record

ArticleInternational journal of molecular sciences2020

Cell Death Mechanisms Induced by CLytA-DAAO Chimeric Enzyme in Human Tumor Cell Lines.

María Fuentes-Baile, Pilar García-Morales, Elizabeth Pérez-Valenciano, María P Ventero, Jesús M Sanz, Camino de Juan Romero, Víctor M Barberá, Cristina Alenda, Miguel Saceda

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Remove, Refine, Reduce: Cell Death in Biological Systems.International journal of molecular sciences · 2023
    Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

María Fuentes-BaileUnidad de Investigación, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Hospital General Universitario de Elche, Camí de l'Almazara, 11, 03203 Elche (Alicante), Spain.ORCID 0000-0003-3653-2407
Pilar García-MoralesInstituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández, Avda. Universidad s/n, Ed. Torregaitán, 03202 Elche (Alicante), Spain.
Elizabeth Pérez-ValencianoInstituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández, Avda. Universidad s/n, Ed. Torregaitán, 03202 Elche (Alicante), Spain.
María P VenteroUnidad de Investigación, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Hospital General Universitario de Alicante, C/Maestro Alonso, 10, 03010 Alicante, Spain.ORCID 0000-0003-1979-0949
Jesús M SanzCentro de Investigaciones Biológicas Margarita Salas (Consejo Superior de Investigaciones Científicas) and Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), C/Ramiro de Maeztu, 9, 28040 Madrid, Spain.ORCID 0000-0002-4421-9376
Camino de Juan RomeroUnidad de Investigación, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Hospital General Universitario de Elche, Camí de l'Almazara, 11, 03203 Elche (Alicante), Spain.ORCID 0000-0001-7890-8447
Víctor M BarberáUnidad de Investigación, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Hospital General Universitario de Elche, Camí de l'Almazara, 11, 03203 Elche (Alicante), Spain.
Cristina AlendaUnidad de Investigación, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Hospital General Universitario de Alicante, C/Maestro Alonso, 10, 03010 Alicante, Spain.ORCID 0000-0002-0560-1759
Miguel SacedaUnidad de Investigación, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO), Hospital General Universitario de Elche, Camí de l'Almazara, 11, 03203 Elche (Alicante), Spain.ORCID 0000-0002-1564-3602
Universitat de Miguel Hernández d'Elx · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESHospital General Universitario de Alicante Doctor Balmis · ESConsejo Superior de Investigaciones Científicas · ES

Funding

Association of women affected by breast cancer in Elche and the region (AMACMEC) DonationConsejo Superior de Investigaciones Científicas 201820I132Instituto de Salud Carlos III PI01202025Instituto de Salud Carlos III RD16/0027/0010Ministerio de Economía, Industria y Competitividad, Gobierno de España BIO2013-47684-RMinisterio de Economía, Industria y Competitividad, Gobierno de España BIO2016-79323-R
6 · The paper itself

Abstract

The combination of the choline binding domain of the amidase N-acetylmuramoyl-L-alanine (CLytA)-D-amino acid oxidase (DAAO) (CLytA-DAAO) and D-Alanine induces cell death in several pancreatic and colorectal carcinoma and glioblastoma cell lines. In glioblastoma cell lines, CLytA-DAAO-induced cell death was inhibited by a pan-caspase inhibitor, suggesting a classical apoptotic cell death. Meanwhile, the cell death induced in pancreatic and colon carcinoma cell lines is some type of programmed necrosis. In this article, we studied the mechanisms that trigger CLytA-DAAO-induced cell death in pancreatic and colorectal carcinoma and glioblastoma cell lines and we acquire a further insight into the necrotic cell death induced in pancreatic and colorectal carcinoma cell lines. We have analyzed the intracellular calcium mobilization, mitochondrial membrane potential, PARP-1 participation and AIF translocation. Although the mitochondrial membrane depolarization plays a crucial role, our results suggest that CLytA-DAAO-induced cell death is context dependent. We have previously detected pancreatic and colorectal carcinoma cell lines (Hs766T and HT-29, respectively) that were resistant to CLytA-DAAO-induced cell death. In this study, we have examined the putative mechanism underlying the resistance in these cell lines, evaluating both detoxification mechanisms and the inflammatory and survival responses. Overall, our results provide a better understanding on the cell death mechanism induced by CLytA-DAAO, a promising therapy against cancer.

Indexed as

Antineoplastic AgentsApoptosisApoptosis Inducing FactorBiopsyCalciumCell DeathCell Line, TumorColorectal NeoplasmsD-Amino-Acid OxidaseGene Expression ProfilingGene Expression Regulation, NeoplasticHT29 CellsHumansInflammationMembrane Potential, MitochondrialN-Acetylmuramoyl-L-alanine AmidaseAIFM1 protein, humanAntineoplastic AgentsApoptosis Inducing FactorCalciumD-Amino-Acid OxidaseDAO protein, humanN-Acetylmuramoyl-L-alanine AmidaseNF-kappa B p50 SubunitNFKB1 protein, humanPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1Reactive Oxygen SpeciesRNA, Small InterferingAIFapoptosiscalcium mobilizationcancer therapymitochondrial membrane potentialnecrotic-like cell deathoxidative damagePARP-1reactive oxygen species

Identifiers

PMID33198289
PMCPMC7697521
OpenAlexW3099316340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.